A message from AUM’s CMO and Leadership Team

The COVID-19 pandemic has affected each one of us in unprecedented ways. In order to improve crisis management during this time, we have established a new agile governance process where our leadership team meets regularly to ensure seamless coordination.

Our first priority is the safety of staff, healthcare professionals, and those we frequently interact with. To limit exposure, we have closed facilities and asked our staff to work remotely.

As clinics and hospitals become inaccessible or as it becomes sometimes unsafe or difficult for patients to travel, we are doing everything in our power to revise our study designs to minimize unnecessary exposure while ensuring science and innovation do not stop. The situation is fluid and we are closely monitoring the situation. We are closely following local health authority and national guidance from competent authorities.

We recognize that we are in a position to support the fight against COVID-19. As per WHO guidelines, we understand that practicing social distancing and reducing dense public gatherings as much as possible is critically important at this time. We urge everyone to take the necessary precautions recommended by the WHO in order to protect ourselves and our community.

This is truly a global effort that requires all of our participation.

For additional information, please visit: https://www.moh.gov.sg/covid-19/resources 

https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19  

https://www.fda.gov/consumers/consumer-updates/how-you-can-make-difference-during-coronavirus-pandemic  

https://www.fda.gov/media/136238/download